32
Participants
Start Date
July 12, 2024
Primary Completion Date
June 30, 2025
Study Completion Date
June 30, 2025
Onureg
Specified dose on specified days
Local Institution - 0012, Buenos Aires
Local Institution - 0011, Pilar
Local Institution - 0074, Hamburg
Local Institution - 9003, Charlottesville
Local Institution - 0015, Pamplona
Local Institution - 0078, Salamanca
Local Institution, Cleveland
Local Institution - 0069, Detroit
Local Institution - 0083, Iowa City
Local Institution - 0076, Augsburg
Local Institution - 0085, Bogotá
Local Institution - 0084, Bogota
Local Institution - 0086, Piedecuesta
Local Institution - 0010, ABB
Local Institution - 0014, Buenos Aires
Local Institution - 0075, Halle
Local Institution - 0018, Badalona
Local Institution - 0017, Barcelona
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY